Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:3846 |
| Name | adamantinous craniopharyngioma |
| Definition | |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Path | disease disease of cellular proliferation benign neoplasm organ system benign neoplasm nervous system benign neoplasm central nervous system benign neoplasm craniopharyngioma adamantinous craniopharyngioma |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03970226 | Phase I | Tocilizumab | Tocilizumab in Children With ACP | Active, not recruiting | USA | 0 |
| NCT05233397 | Phase II | Tocilizumab | ACTEMRA for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Recruiting | USA | CAN | AUS | 0 |
| NCT05286788 | Phase II | Binimetinib | MEKTOVI for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Recruiting | USA | CAN | AUS | 0 |